Delivery Order SPE2DB25D3020-SPE2DB25FWKDD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $1,394.19, with an ultimate completion date of August 15, 2025. The contract involves no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,273.53 on July 28, 2025, for the supply of Febuxostat 80 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 29, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,514.92 and an ultimate completion date of August 15, 2025. The contract was competitively awarded without set-aside designation, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Febuxostat 40 mg tablets (30-count packages) under a firm fixed-price contract valued at $4,061.04. This non-set-aside, competitively awarded delivery order is scheduled for completion by August 12, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,518.00 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,497,445 units of Febuxostat 40 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Febuxostat 40 mg tablets. The $2,437.82 firm fixed-price contract has an ultimate completion date of December 7, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Febuxostat 80 mg tablets. The contract has a ceiling value of $5,765.20 and an ultimate completion date of September 23, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen is the prime contractor, and the award is part of a larger Indefinite Delivery Contract (IDC) valued up to...
- This is a $1,675.64 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product Febuxostat 40 mg tablets, supplied in 30-count packages. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to provide a wide range of pharmaceuticals and medical supplies to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FEBUXOSTAT 40 MG TABLET 30S. The contract has a firm fixed price of $1,494.03 and an ultimate completion date of May 20, 2025. The award was made on May 19, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a $1,460.47 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of 4568275407 - FEBUXOSTAT 40 MG TABLET 30S. The delivery order has an ultimate completion date of May 19, 2025 and is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKDDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Febuxostat 80 mg tablets in quantities of 30, with a contract ceiling value of $1,191.79. This is a firm fixed price delivery order with an ultimate completion date of August 21, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical supply needs, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical support vehicle enables the company to supply medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. The Febuxostat order represents a routine pharmaceutical delivery supporting the agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/20/25 |